Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Oxford scientists probe why nerve exercises ease carpal tunnel pain

NCT ID NCT05859412

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study from the University of Oxford aims to understand how specific physiotherapy exercises (neurodynamic exercises) work for carpal tunnel syndrome. Researchers will compare these exercises to standard steroid injections and simple advice in 78 patients with mild to moderate carpal tunnel syndrome, plus 30 healthy volunteers. Using advanced MRI scans, nerve tests, and blood samples, they hope to uncover the biological mechanisms behind the exercises' effects.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neurodynamic exercises (nerve and tendon gliding exercises) and steroid injection (Depomedrone 40mg)
What this could lead to
If successful, this could help doctors better target physiotherapy exercises to patients who will benefit most, potentially reducing the need for surgery.
What could go wrong
This is a small, early-stage mechanistic study focused on understanding how treatments work, not on proving they are effective. Results may not change clinical practice directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

May 2023

Finished

Feb 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria Patients: 1. Patients who have a diagnosis of mild to moderate carpal tunnel syndrome based on a clinical assessment and confirmed with nerve conduction studies. 2. Male or Female, aged 18 years or above. 3. Patient is willing and able to give informed consent for participation in the study. Healthy participants: 1. Male or female aged 18 years or above. 2. Participant is willing and able to give informed consent for participation in the study. 3. No history of hand or arm symptoms 4. No history of neck pain in the past 3 months 5. No systemic medical condition 6. No strong anticoagulant medication or altered coagulation (e.g., hemophilia) preventing skin biopsies 7. Severe anxiety or depression 8. Participants are required to be age- \& sex-matched to patient participants 9. No contraindications for magnetic resonance scanning at 3T 10. Sufficient command of the English language Exclusion Criteria Patients: 1. Patients who already had surgery for their carpal tunnel syndrome (CTS) or are planning to undergo surgery in the next 6 weeks (patients with unilateral surgery who have unoperated CTS on the other hand are eligible to participate) 2. Patients who had a steroid injection for their CTS in the 6 months prior to the study enrolment or who had already more than 1 steroid injection into the study wrist. 3. Patients who have a diagnosis of severe carpal tunnel syndrome based on a clinical assessment and confirmed with electrodiagnostic testing 4. Electrodiagnostic testing revealing abnormalities other than CTS 5. Any other upper limb or neck problem for which they have sought treatment in the past 3 months 6. History of significant trauma to the upper limb or neck 7. Diabetes 8. Hypothyroidism 9. Severe anxiety or depression 10. Patient who is pregnant, lactating, or planning pregnancy during the study. 11. Patients on strong anticoagulant medication or altered coagulation preventing skin biopsies. 12. Contraindications for magnetic resonance imaging (assessed with MRI safety screening questionnaire). 13. Contraindications for steroid injections 14. Insufficient command of the English language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Carpal tunnel syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nuffield Department of Clinical Neurosciences, University of Oxford

    Oxford, Oxfordshire, OX3 9DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.